Atrium Innovations has announced the development of ChroNOline (INCI: glycerin (and) water (aqua) (and) dextran (and) caprooyl tetrapeptide-3), a biomimetic tetrapeptide derived from a growth factor. The ingredient design is linked to a lipid for higher stability and optimal skin penetration. The company reports the material boosts the production of key components like collagen VII, laminin-5 and fibronectin for optimal skin structural support. The ingredient is presented as providing an outstanding reduction of the appearance of fine lines and wrinkles after only 28 days. For more information, visit www.atrium-innov.com.